Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nordic Nanovector: Protocol Amendment filed in the UK to enable initiation of Phase 2 PARADIGME

Oslo, Norway, 8 November 2017 Nordic Nanovector ASA (OSE: NANO) notes that information relating to an application for a Protocol Amendment to the LYMRIT 37-01 study, for the planned pivotal Phase 2b clinical trial PARADIGME to evaluate Betalutin® (177Lu-lilotomab satetraxetan) in recurrent/relapsed follicular lymphoma has been published by MHRA (Medicines and Healthcare products Regulatory Agency). The application for the Protocol Amendment is under-going review by the MHRA. The board of directors of Nordic Nanovector will decide on the final structure and initiation of the study upon

Meet Senzime at Medica Trade Fair in Düsseldorf, 13-16 November

Uppsala, November 8, 2017. Medica Trade Fair in Düsseldorf is the world's leading trade fair for the medical industry. The fair consists of 17 halls where exhibitors from all over the world will present their products. Welcome to meet Senzime at Medica to learn more about our patient monitoring products OnZurf Probe, CliniSenz Analyzer and TetraGraph. Senzime is co-exhibiting with Business Sweden in Hall 3A/3AE29 . Please book a meeting with us – send an

Swedish ICA stores – October sales figures

Sales in the Swedish ICA stores increased by 3.4% in October 2017 compared with the corresponding month last year. Sales in like-for-like stores increased by 2.6%.+-----------+-----+-------+--------+-------+-------+--------+| | October | January || | 2017 | – Octobe || | | r 2017 |+-----------+-----+-------+--------+-------+-------+--------+|Store sales| Mkr|Change | Change| Mkr|Change | Change||excl. VAT | | all|like-for| | all|like-

Ginolis Announces Distribution Agreement with Darwin Microfluidics for Dispensing Pumps

Ginolis , a global supplier of production automation and dispensing solutions, today announced a distributor agreement with Darwin Microfluidics , an online supplier of microfluidic kits, products and accessories.    The distribution agreement represents a major step for Ginolis in making its’ patented dispensing technology available to researchers and scientists around the world. The agreement grants Darwin Microfluidics, the right to market and sell Ginolis’ Piezo Motor Bellows (PMB) pumps, accessories and starter kits. “Ginolis

Moberg Pharma provides update on timeline for MOB-015

STOCKHOLM, November 8th 2017, Moberg Pharma AB (OMX: MOB) today announced an updated timeline for patient recruitment to the ongoing Phase 3 studies for MOB-015, with recruitment in the North American study expected to be completed during the summer 2018 and recruitment in the European study expected to be completed in the second half of 2018.Recruitment to the Phase 3 studies for MOB-015, a proprietary topical formulation of terbinafine for the treatment of onychomycosis, is underway simultaneously in North America and Europe. However, a significantly higher screening failure rate than

Improving Automotive Passive Safety Protection for an Aging Population

(Stockholm, Sweden, November 8, 2017) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, is performing crash tests in order to develop restraint systems for a population that is getting older and more diverse. Now, Autoliv is conducting research on a new crash dummy that represents an elderly female.Passive safety requirements continue to develop through research. The target in current legislation and rating programs (such as Euro NCAP) are male, with just a few exceptions. To save more lives, Autoliv goes beyond legislations and rating programs.

SaltX agrees to sell exclusive license for its gas heat pump technology in China

- Partnering with Stjernberg Automation and TUS Holding SaltX Technology – listed on NASDAQ First North in Stockholm – has agreed on the key terms of a licensing and collaboration agreement with Stjernberg Automation AB and its Chinese Joint Venture - TUS Stjernberg Technology Co, Ltd. The term sheet stipulates that Stjernberg will pay SaltX 10 million RMB for exclusive rights to manufacture and sell SaltX HeatBoost components and products in China. The amount includes technical support from SaltX during the first two years and is paid in four equal instalments provided certain volume- and

Medivir Announces New Cancer Project, Leukotide, derived from its in-house Nucleotide Platform

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces a new discovery project for a cancer indication. The Leukotide project is intended to deliver a new drug for the treatment of acute myeloid leukemia (AML) and other hematological malignancies, and is based on the company’s expertise in nucleoside and nucleotide science. It represents the second cancer project to emerge from its in-house discovery efforts in oncology. AML arises from cells in the bone marrow that are supposed to develop into normal white blood cells but become cancerous instead. These cancerous cells

Alfa Laval appoints Jan Allde to new Chief Financial Officer, from early 2018

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – today announces that Thomas Thuresson, CFO of the Alfa Laval Group, has decided to go into early retirement and that Jan Allde has been appointed new CFO, effective February 1, 2018.“Thomas has played a key strategic role in the transformation of Alfa Laval into the company we are today. His financial expertise, including the wide and deep business insight, has served us very well over a 25-year period of continuous development,” says Tom Erixon, President and CEO of the Alfa Laval Group. “I am very

Cantargia publishes interim report for third quarter of 2017

Cantargia AB’s (”Cantargia”) interim report for the third quarter of 2017 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the third quarter  In July Cantargia received approval to initiate its clinical phase I/IIa study, named CANFOUR, with the CAN04 antibody in patients with cancer. Cantargia’s application had then been approved by regulatory authorities and ethics committees in Denmark and Norway. During the period Magnus Persson, Chairman, and Göran Forsberg, CEO, subscribed for 85,000 warrants and 14,000 shares,

Scania’s latest gas engine designed for long-distance transport

· Scania’s new gas engine is designed for long-distance transport and on construction sites.          · 410 horsepower and 2,000 Nm – well in line with diesel engines of a similar size. · A service interval of 45,000 km ensures high availability.  Scania’s launch of the OC13 gas engine marks the start of alternative fuel solutions for the new truck generation. The OC13 is based on Scania’s well-proven 13-litre engine. The engine works according to the Otto principle with spark plugs and complete combustion.There is a growing interest in operating vehicles on biogas or natural gas

Etrion to Release Third Quarter 2017 Results on November 14, 2017

November 8, 2017, Miami, Florida – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its third quarter 2017 results before the market opens on Tuesday, November 14, 2017.   Earnings Call A conference call/webcast to present the Company’s third quarter 2017 results will be held on Tuesday, November 14, 2017, at 10:00 a.m. Eastern Standard Time (EDT) / 4:00 p.m. Central European Time (CET).   Dial-in details: North America: +1-647-788-4919 / Toll Free: +1-877-291-4570 / Sweden Toll Free: 02-079-4343 Webcast:

SteriKraft® Protect S joins BillerudKorsnäs protect paper range

BillerudKorsnäs SteriKraft® Protect, manufactured from pure cellulose with no polymeric additions, is a unique medical packaging paper which is up to 20 percent stronger gram for gram than a normal paper. This gives a very special range of properties. The paper is fully compatible with direct seal films and highly cost effective, whilst offering substantially more protection for the packed device.Building on the existing SteriKraft® Protect EO for low temperature sterilisation (EtO & Radiation), Protect S brings full compatibility with steam sterilisation (134°C) with high porosity and

Bactiguard secures three-year financing

Bactiguard has received a commitment for a three-year credit facility of SEK 180 million from Skandinaviska Enskilda Banken (SEB), in the form of an overdraft facility of SEK 30 million and a term loan of SEK 150 million. The credit facility replaces current bank financing as well as a loan from the company's main shareholders."For some time, we have been working actively to refinance Bactiguard at attractive terms. Therefore, we are pleased to announce that we have secured a three-year credit facility with our new house bank SEB, which replaces both current bank financing and the loan from

Interim Report January – September 2017

BioArctic listed on Nasdaq Stockholm Mid Cap July - September 2017 ·  Net sales for the period amounted to SEK 31.5 million (1.2) ·  Operating profit amounted to SEK 0.6 million (-10.2) ·  Loss for the period amounted to SEK -0.1 million (-7.8) ·  Earnings per share SEK 0.00 (-0.12) ·  Cash flow from operating activities amounted to SEK -23.6 million (-9.8) January - September 2017 ·  Net sales for the period amounted to SEK 89.7 million (11.2) ·  Operating profit amounted to SEK 4.6 million (-22.7) ·  Profit/loss for the period amounted to SEK 3.3 million (

Interim report January – September 2017

Continued strong organic growth and improved marginJuly – September ·Revenue rose 17.9% to MEUR 69.2 (58.7) ·Organic growth was 7.1% ·The gross margin increased to 42.4% (41.0) ·Adjusted EBITA increased to MEUR 6.3 (4.5), corresponding to a margin of 9.1% (7.7) ·Adjusted EBIT rose to MEUR 5.2 (3.5), corresponding to a margin of 7.5% (5.9) ·Part of the Puls business unit was divested on 1 August 2017 and reported under divested operations ·Handicare was listed on Nasdaq Stockholm on 10 October 2017 following a new share issue. As a result of

BillerudKorsnäs Launches SteriKraft® Protect AR – a new polymer reinforced medical paper

To answer the need for higher performance medical packaging systems, following the standardization regarding Packaging for terminally sterilized medical devices, BillerudKorsnäs has developed and now launches a new polymer reinforced paper SteriKraft® Protect AR.The standardization, Packaging for terminally sterilized medical devices ISO 11607-1, 5.5 Storage & Transport, has led to more rigorous and realistic ship testing protocols which have, in turn, shown the need for higher performance medical device packaging systems. To answer this need, BillerudKorsnäs has developed a new polymer

Catella: Risk evaluation reveals good investment opportunities in Europe

In the latest Catella Market Tracker “Commercial Real Estate Investments in Europe – Risk Evaluation in Times of Boom and Uncertainty”, an analysis of 28 European real estate locations shows a good basis for long-term yield generation based on the common risk key indicators – risk/yield, volatility and Sharpe ratio.The analysis of 28 European locations in an office and retail portfolio shows an average total return of 7.95% at the end of 2017. · The top-5 performers are Dublin (12.1 %), Lyon (10.4 %), Stockholm (10.2 %), Paris (9.9 %), Barcelona (9.8 %) and Marseilles (9.8 %). · The

CONCENTRIC INTERIM REPORT JANUARY – SEPTEMBER 2017

THIRD QUARTER ·  Net sales: MSEK 515 (491) – up 8% y-o-y, after adjusting for currency (–3%).  ·  Operating income: MSEK 96 (81), generating an operating margin of 18.7% (16.5). ·  Earnings after tax: MSEK 72 (59); basic EPS of SEK 1.79 (1.45). ·  Cash flow generated from operating activities: MSEK 73 (113) is lower mainly due to increase in working capital. ·  Group’s net debt: MSEK 317 (559); gearing ratio of 41% (81) mainly due to recovery from pension remeasurement losses last year. FIRST NINE MONTHS ·  Net sales: MSEK 1,601 (1,531) – up 4% y-o-y, after

Announcement of managers' transactions: Michael Rosenlew, Chairman of the Board, has purchased shares in Caverion Corporation

Caverion Corporation Stock exchange release November 8, 2017 at 9.00 a.m. EETAnnouncement of managers' transactions: Michael Rosenlew, Chairman of the Board, has purchased shares in Caverion Corporation Person subject to the notification requirement Name: Rosenlew, Michael Position: Member of the Board/Deputy member Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number: 7437007ECQWVPCJIS695_20171107145414_2 ____________________________________________ Transaction date: 2017-11-06 Venue: NASDAQ HELSINKI LTD (XHEL)

Hansa Medical announces sudden death of CEO Göran Arvidson

"It is with great regret that we announce the passing of Göran Arvidson which is both deeply tragic and completely unexpected," said Ulf Wiinberg, Chairman of Hansa Medical. "Göran Arvidson has left us suddenly and unexpectedly. Our thoughts go to Göran's family and to those closest to him." Göran Arvidson was recruited to Hansa Medical as CFO in January 2015. He became acting CEO shortly afterwards and was appointed permanent CEO on April 30th the same year. He has had long and successful career in the pharmaceutical industry, including senior positions at Pharmacia and Biovitrum (Sobi).

Swisscom selects Ericsson as strategic supplier for Gigabit LTE and 5G

· Swisscom and Ericsson reaffirm their long-standing, strategic partnership by continuing to drive innovation in Gigabit LTE and 5G · Ericsson to provide complete digital transformation of Swisscom’s network to nationwide Gigabit LTE and deployment of 5G · Transformation includes the deployment of Ericsson’s full stack telco cloud solution with network slicing technologies, and 5G portfolio offering with Massive MIMOSwisscom, the leading telecommunications provider in Switzerland, has selected Ericsson (NASDAQ: ERIC) for complete digital transformation and evolution of its entire

Nexam Chemical Holding AB (publ) Interim Financial Report 1 January – 30 September 2017

Continued good development within high performanceThird quarter at a glance Operational: ·Continued growth within high performance. ·New product developed, NEXIMID® 800, within high performance in collaboration with existing customer. ·Patent application relating to a cross-linkable nylon has been approved in Europe. Financials: ·Net sales for the third quarter totaled SEK 2,090,000 (1,113,000). ·The operating loss for the third quarter SEK -4,022,000 (-5,411,000). ·In comparison to the beginning of the year, cash and cash equivalents amounted

Nixu attempts to hack an elevator as part of IoT cybersecurity awareness event

Nixu’s IoT Wreckathon event helps companies to improve cybersecurity and raise security awareness in their R&D organizations.Nixu CorporationPress release, November 8, 2017 at 9:00 AM EET Nixu attempts to hack an elevator as part of IoT cybersecurity awareness event Nixu’s IoT Wreckathon event helps companies to improve cybersecurity and raise security awareness in their R&D organizations.The prediction of all the products in the world being connected is getting closer year by year. The estimates on how many connected devices there will be in 2020 range from 30 billion to over 200

There are no items matching the current filter
There are no more items matching the current filter
Back to top